Lazard Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Sell |
|
|||||
|
2025
Q1 | $3.21M | Sell |
|
|||||
|
2024
Q4 | $5.69M | Buy |
|
|||||
|
2024
Q3 | $5.47M | Sell |
|
|||||
|
2024
Q2 | $7.48M | Buy |
|
|||||
|
2024
Q1 | $538K | Sell |
|
|||||
|
2023
Q4 | $3.73M | Buy |
|
|||||
|
2023
Q3 | $2.8M | Buy |
|
|||||
|
2023
Q2 | $177K | Buy |
|
|||||
|
2023
Q1 | $117K | Buy |
|
|||||
|
2022
Q4 | $116K | Sell |
|
|||||
|
2022
Q3 | $12M | Buy |
|
|||||
|
2022
Q2 | $105K | Sell |
|
|||||
|
2022
Q1 | $173K | Buy |
|
|||||
|
2021
Q4 | $122K | Sell |
|
|||||
|
2021
Q3 | $332K | Sell |
|
|||||
|
2021
Q2 | $328K | Buy |
|
|||||
|
2021
Q1 | $148K | Buy |
|
|||||
|
2020
Q4 | $80K | Buy |
|
|||||
|
2020
Q3 | $87K | Sell |
|
|||||
|
2020
Q2 | $481K | Buy |
|
|||||
|
2020
Q1 | $129K | Buy |
|
|||||
|
2019
Q4 | $30K | Buy |
|
|||||
|
2019
Q3 | $15K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $613K | Hold |
|
|||||
|
2018
Q1 | $741K | Buy |
|
|||||
|
2017
Q4 | $730K | Buy |
|